Open-label Study to Assess the Safety and Efficacy of CDP6038 in Patients Who Completed RA0056
|ClinicalTrials.gov Identifier: NCT01296711|
Recruitment Status : Completed
First Posted : February 15, 2011
Last Update Posted : August 27, 2014
UCB BIOSCIENCES, Inc.
Information provided by (Responsible Party):
UCB Pharma ( UCB BIOSCIENCES, Inc. )
Results Submitted - Not Posted on ClinicalTrials.gov
Results information has been submitted to ClinicalTrials.gov by the sponsor or investigator, but is not yet publicly available (or "posted") on ClinicalTrials.gov. The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
|Recruitment Status :||Completed|
|Primary Completion Date :||May 2013|
|Study Completion Date :||August 2013|
|Certification or Request for Extension to Delay Results Submission:||June 3, 2013|
|Submission Cycle||Results Submitted to ClinicalTrials.gov||Results Returned after Quality Control Review|
|1||January 27, 2017||March 17, 2017|